OUR PROCESS ABOUT HEMATECH NEWS & PUBLICATIONS

HOME  |  CAREERS  |  CONTACT US

	ALL NEWS 4/9/2008 Hematech wins Business of the Year 1/3/2007 FIRST PRION-FREE COWS REPORTED IN NATURE BIOTECHNOLOGY - Hematech Scientific Team Knock Out Prion Protein Gene in Cattle 6/9/2006 Kirin Acquires Remaining Shares of Hematech, LLC and mergers create Hematech, Inc. 7/25/2005 Kirin to Acquire Hematech, LLC 2/10/2005 Life Therapeutics' Development Agreement with Hematech Confirms Scalability and Efficacy of Gradiflow 7/28/2004 Hematech Receives Second $3 Million Congressional Appropriation 6/2/2004 Hematech Achieves Milestone in Development of Human Polyclonal Antibody Production System 4/14/2004 Life Therapeutics and Hematech Agree to a Pre Production Study after Successful Completion of Phase One Gradiflow for Antibody Purification 10/28/2003 CHROMATIN TRANSFER PROMISES TO IMPROVE SURVIVAL, EFFICIENCY IN CATTLE CLONING, JOURNAL REPORTS 9/25/2003 Daschle Announces Approval of $3 Million for Defense Department Bioterror Response System in South Dakota 7/18/2003 Hematech expansion is type of development that South Dakota needs 7/14/2003 Gov. Rounds Recommends $7.5 million for Hematech 10/30/2002 Hematech Wins $3.3 M U.S. Government Contract through DynPort Vaccine Company LLC to Develop Protective Antibodies against Potential Bioweapons Agent, Botulinum Neurotoxins 8/12/2002 Researchers Create Potential New Source of Human Antibodies from Cows 5/29/2002 Hematech Research Laboratory Opens in Sioux Falls, South Dakota			All News > Back to News & Publications >Read Publications

	©2002-2012 Hematech, Inc., A Subsidiary of Kyowa Hakko Kirin Company, Ltd. All Rights Reserved.